| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Department of Microbiology and Immunology, Kimmel Cancer Institute, Thomas Jefferson University, Philadelphia, PA 19107; and
Section of Immunobiology, Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT 06520
We examined the role of reduction in the presentation of two H2-Ed-restricted epitopes (site 1 epitope (S1) and site 3 epitope (S3)) occupying distinct domains of the influenza hemagglutinin major subunit that contains four intrachain disulfide bonds and is connected to the virion by one interchain bond. S3 is situated within the stalk region that unfolds in response to mild acidification, and loads onto recycling H2-Ed in the early endosome, while S1, located in the structurally constrained globular domain, loads onto nascent H2-Ed in the late endosome. Predicting dependence upon reduction for either epitope seemed plausible but the results from several approaches were clear: presentation of S1 but not S3 is reduction dependent. Surprisingly, IFN-
-inducible lysosomal thiol reductase (GILT), the only reductase thus far known to be involved in MHC class II-restricted processing, is not necessary for the generation of S1. However, GILT is necessary for presentation of either epitope when the virus is pretreated with a reducible cross-linker. The results suggest that unfolding of the Ag, perhaps a prerequisite for proteolytic processing in many cases, proceeds either spontaneously in the early endosome or via reduction in a later endosome. They further imply mechanisms for GILT-independent reduction in the late endosome, with GILT perhaps being reserved for more intractable Ags.
This article has been cited by other articles:
|
|
 |
|
  R. Sealy, W. Chaka, S. Surman, S. A. Brown, P. Cresswell, and J. L. Hurwitz Target Peptide Sequence within Infectious Human Immunodeficiency Virus Type 1 Does Not Ensure Envelope-Specific T-Helper Cell Reactivation: Influences of Cysteine Protease and Gamma Interferon-Induced Thiol Reductase Activities Clin. Vaccine Immunol., April 1, 2008; 15(4): 713 - 719. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Landry Three-Dimensional Structure Determines the Pattern of CD4+ T-Cell Epitope Dominance in Influenza Virus Hemagglutinin J. Virol., February 1, 2008; 82(3): 1238 - 1248. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kreiter, A. Selmi, M. Diken, M. Sebastian, P. Osterloh, H. Schild, C. Huber, O. Tureci, and U. Sahin Increased Antigen Presentation Efficiency by Coupling Antigens to MHC Class I Trafficking Signals J. Immunol., January 1, 2008; 180(1): 309 - 318. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Barjaktarevic, A. Rahman, S. Radoja, B. Bogunovic, A. Vollmer, S. Vukmanovic, and M. Maric Inhibitory Role of IFN-{gamma}-Inducible Lysosomal Thiol Reductase in T Cell Activation J. Immunol., October 1, 2006; 177(7): 4369 - 4375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Lackman and P. Cresswell Exposure of the Promonocytic Cell Line THP-1 to Escherichia coli Induces IFN-{gamma}-Inducible Lysosomal Thiol Reductase Expression by Inflammatory Cytokines J. Immunol., October 1, 2006; 177(7): 4833 - 4840. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. D. Austin, X. Wen, L. Gazzard, C. Nelson, R. H. Scheller, and S. J. Scales Oxidizing potential of endosomes and lysosomes limits intracellular cleavage of disulfide-based antibody-drug conjugates PNAS, December 13, 2005; 102(50): 17987 - 17992. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
